Literature DB >> 8149662

Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone.

G Fantuzzi1, M T Demitri, P Ghezzi.   

Abstract

Glucocorticoids (GC) are well known inhibitors of tumour necrosis factor (TNF) production. We investigated the role of endogenous GC in the regulation of TNF production in mice treated with lipopolysaccharide (LPS) using a pretreatment with dexamethasone (DEX) to down-regulate the hypothalamus-pituitary-adrenal axis (HPA). Short-term DEX pretreatment (up to 12 h before LPS) inhibited TNF production, but earlier (24-48 h) pretreatments potentiated it. This up-regulating effect was not observed in adrenalectomized mice or when GC synthesis was inhibited with cyanoketone (CK). This effect could not be explained only by the suppression of LPS-induced corticosterone (CS) levels induced by DEX, since a 48-h pretreatment potentiated TNF production without affecting LPS-induced CS levels. On the other hand, mice chronically pretreated with DEX were still responsive to its inhibitory effect on TNF production, thus ruling out the possibility of a decreased responsiveness to GC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149662      PMCID: PMC1534547          DOI: 10.1111/j.1365-2249.1994.tb06247.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

2.  Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.

Authors:  S H Zuckerman; J Shellhaas; L D Butler
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

3.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

4.  Stoichiometric inhibition of various 3-beta-hydroxysteroid dehydrogenases by a substrate analogue.

Authors:  A S Goldman
Journal:  J Clin Endocrinol Metab       Date:  1967-03       Impact factor: 5.958

Review 5.  Glucocorticoid receptor regulation.

Authors:  F Svec
Journal:  Life Sci       Date:  1985-06-24       Impact factor: 5.037

6.  Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat.

Authors:  S A Wrighton; E G Schuetz; P B Watkins; P Maurel; J Barwick; B S Bailey; H T Hartle; B Young; P Guzelian
Journal:  Mol Pharmacol       Date:  1985-09       Impact factor: 4.436

7.  Human tumor necrosis factor. Production, purification, and characterization.

Authors:  B B Aggarwal; W J Kohr; P E Hass; B Moffat; S A Spencer; W J Henzel; T S Bringman; G E Nedwin; D V Goeddel; R N Harkins
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

8.  Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha.

Authors:  L D Butler; N K Layman; P E Riedl; R L Cain; J Shellhaas; G F Evans; S H Zuckerman
Journal:  J Neuroimmunol       Date:  1989-09       Impact factor: 3.478

9.  Modification of the murine immune system by glucocorticosteroids: alterations of the tissue localization properties of circulating lymphocytes.

Authors:  H T Chung; W E Samlowski; R A Daynes
Journal:  Cell Immunol       Date:  1986-09       Impact factor: 4.868

10.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

View more
  4 in total

1.  Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.

Authors:  Mark P Yeager; Athos J Rassias; Patricia A Pioli; Michael L Beach; Kathleen Wardwell; Jane E Collins; Hong-Kee Lee; Paul M Guyre
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

2.  Adrenalectomy enhances response of tumour necrosis factor-alpha (TNF-alpha) to haemorrhage in the conscious rat.

Authors:  M Yamashita; M Yamashita
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?

Authors:  Marco Confalonieri; Djillali Annane; Caterina Antonaglia; Mario Santagiuliana; Ediva M Borriello; G Umberto Meduri
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 4.  The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.

Authors:  Marc-André Bellavance; Serge Rivest
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.